122 results
Page 4 of 7
DEFA14A
3i4onk
17 Feb 22
Additional proxy soliciting materials
5:18pm
S-8
020l1ch3 xpi
25 Jan 22
Registration of securities for employees
4:27pm
DEFA14A
rd4nalvyr
18 Jan 22
Additional proxy soliciting materials
5:20pm
DEFA14A
odv5w 1fv
18 Jan 22
Additional proxy soliciting materials
10:43am
424B3
cg5hsx5suk3wjkka
18 Jan 22
Prospectus supplement
9:30am
8-K
EX-2.1
92sec9323q
18 Jan 22
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
9:14am
8-K
EX-99.1
qmoqip28
18 Jan 22
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
9:14am
8-K
EX-99.2
k1z19raualflioizj3va
18 Jan 22
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
9:14am
8-K
EX-10.2
03ql9ou
18 Jan 22
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
9:14am
8-K
8ryxdweqqj
18 Jan 22
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
9:14am
8-K
EX-99.1
9qfsw5 mn
10 Jan 22
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
8:56am
424B3
4k25gya66ywpef
15 Nov 21
Prospectus supplement
5:20pm
8-K
EX-99.1
hbnsj2nvb4 e1ht
15 Nov 21
Sema4 Reports Third Quarter 2021 Financial Results and Business Highlights
4:19pm
S-8
tjg4pi
27 Sep 21
Registration of securities for employees
4:46pm
8-K
EX-99.1
l53vjef1ac0u4s2a8joc
16 Aug 21
Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights
4:31pm
424B3
nhfl2adh0g5
12 Aug 21
Prospectus supplement
5:00pm
8-K
EX-10.2
51ulkut qkaus8nh
28 Jul 21
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
5:24pm
8-K
EX-99.1
0n7thlkff
28 Jul 21
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
5:24pm